BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31882460)

  • 1. Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039.
    Epperly MW; Fisher R; Zhang X; Hou W; Shields D; Wipf P; Wang H; Thermozier S; Greenberger JS
    In Vivo; 2020; 34(1):33-38. PubMed ID: 31882460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca
    Willis J; Epperly MW; Fisher R; Zhang X; Shields D; Hou W; Wang H; Li S; Wipf P; Parmar K; Guinan E; Steinman J; Greenberger JS
    Radiat Res; 2018 Jun; 189(6):560-578. PubMed ID: 29584588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of Mucositis in Proton Therapy of Fanconi Anemia Fanca
    Quinn TJ; Ding X; Li X; Wilson GD; Buelow K; Sivananthan A; Thermozier S; Henderson A; Epperly MW; Franicola D; Wipf P; Greenberger JS; Stevens CW; Kabolizadeh P
    In Vivo; 2019; 33(6):1757-1766. PubMed ID: 31662500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.
    Berhane H; Shinde A; Kalash R; Xu K; Epperly MW; Goff J; Franicola D; Zhang X; Dixon T; Shields D; Wang H; Wipf P; Li S; Gao X; Greenberger JS
    Radiat Res; 2014 Jul; 182(1):35-49. PubMed ID: 24932534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Is Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350.
    Epperly MW; Rhieu BH; Franicola D; Dixon T; Cao S; Zhang X; Shields D; Wang H; Wipf P; Greenberger JS
    In Vivo; 2017; 31(2):159-168. PubMed ID: 28358695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Ferroptosis Drug Enhances Total-Body Irradiation Mitigation by Drugs that Block Apoptosis and Necroptosis.
    Thermozier S; Hou W; Zhang X; Shields D; Fisher R; Bayir H; Kagan V; Yu J; Liu B; Bahar I; Epperly MW; Wipf P; Wang H; Huq MS; Greenberger JS
    Radiat Res; 2020 May; 193(5):435-450. PubMed ID: 32134361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.
    Bernard ME; Kim H; Berhane H; Epperly MW; Franicola D; Zhang X; Houghton F; Shields D; Wang H; Bakkenist CJ; Frantz MC; Forbeck EM; Goff JP; Wipf P; Greenberger JS
    Radiat Res; 2011 Nov; 176(5):603-12. PubMed ID: 21939290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca
    Sivananthan A; Shields D; Fisher R; Hou W; Zhang X; Franicola D; Epperly MW; Wipf P; Greenberger JS
    Radiat Res; 2019 Feb; 191(2):139-153. PubMed ID: 30499383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
    Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
    Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation Mitigators.
    Epperly MW; Sacher JR; Krainz T; Zhang X; Wipf P; Liang M; Fisher R; Li S; Wang H; Greenberger JS
    In Vivo; 2017 Jan; 31(1):39-43. PubMed ID: 28064218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiologic effects of GS-nitroxide (JP4-039) on the hematopoietic syndrome.
    Goff JP; Epperly MW; Dixon T; Wang H; Franicola D; Shields D; Wipf P; Li S; Gao X; Greenberger JS
    In Vivo; 2011; 25(3):315-23. PubMed ID: 21576404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved hematopoiesis in GS-nitroxide (JP4-039)-treated mouse long-term bone marrow cultures and radioresistance of derived bone marrow stromal cell lines.
    Shinde A; Epperly MW; Cao S; Holt D; Goff J; Shields D; Franicola D; Wipf P; Wang H; Greenberger JS
    In Vivo; 2014; 28(5):699-708. PubMed ID: 25189880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.
    Shinde A; Berhane H; Rhieu BH; Kalash R; Xu K; Goff J; Epperly MW; Franicola D; Zhang X; Dixon T; Shields D; Wang H; Wipf P; Parmar K; Guinan E; Kagan V; Tyurin V; Ferris RL; Zhang X; Li S; Greenberger JS
    Radiat Res; 2016 Feb; 185(2):134-50. PubMed ID: 26789701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators.
    Rwigema JC; Beck B; Wang W; Doemling A; Epperly MW; Shields D; Goff JP; Franicola D; Dixon T; Frantz MC; Wipf P; Tyurina Y; Kagan VE; Wang H; Greenberger JS
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):860-8. PubMed ID: 21493014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Different Formulations and Routes for the Delivery of the Ionizing Radiation Mitigator GS-Nitroxide (JP4-039).
    Epperly MW; Wipf P; Fisher R; Franicola D; Beumer J; Li S; Brand RM; Falo LD; Erdos G; Greenberger JS
    In Vivo; 2018; 32(5):1009-1023. PubMed ID: 30150422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways.
    Steinman J; Epperly M; Hou W; Willis J; Wang H; Fisher R; Liu B; Bahar I; McCaw T; Kagan V; Bayir H; Yu J; Wipf P; Li S; Huq MS; Greenberger JS
    Radiat Res; 2018 Jan; 189(1):68-83. PubMed ID: 29140165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of radiation esophagitis by orally administered p53/Mdm2/Mdm4 inhibitor (BEB55) or GS-nitroxide.
    Kim H; Bernard ME; Epperly MW; Shen H; Amoscato A; Dixon TM; Doemling AS; Li S; Gao X; Wipf P; Wang H; Zhang X; Kagan VE; Greenberger JS
    In Vivo; 2011; 25(6):841-8. PubMed ID: 22021675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.